Title | Cardiovascular Disease in Diabetes [electronic resource] : Proceedings of the Symposium on the Diabetic Heart sponsored by the Council of Cardiac Metabolism of the International Society and Federation of Cardiology and held in Tokyo, Japan, October 1989 / edited by Makoto Nagano, Seibu Mochizuki, Naranjan S. Dhalla |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 1992 |
Connect to | http://dx.doi.org/10.1007/978-1-4615-3512-6 |
Descript | XV, 388 p. online resource |
A. Evaluation of Cardiovascular Problems in Diabetes -- 1. Assessment of cardiac function in diabetic patients by impedance cardiography -- 2. Early diastolic dysfunction of left ventricle and its relation to pathologic finding in patients with diabetes mellitus -- 3. Radionuclide assessment of left ventricular function in middle-aged asymptomatic non-insulin-dependent diabetic patients -- 4. Usefulness of exercise Tl-201 myocardial scintigraphy to detect asymptomatic heart disease in diabetic patients -- 5. Autonomic function test assessed by ambulatory ECG in diabetes -- 6. Diabetic albuminuria and ischemic heart disease -- 7. Prognostic significance of treadmill exercise stress test in diabetic patients without cardiovascular signs -- 8. Coronary artery bypass grafting in the diabetic heart: Myocardial tolerance during surgery and late result -- B. Interactions of Diabetes and Hypertension -- 9. The influence of diabetes on myocardial contractility and energetics in spontaneously hypertensive rats -- 10. Hypertensive-diabetic cardiomyopathy in rats -- 11. Combined effects of hypertension and diabetes on myocardial contractile proteins and cardiac function in rats 95 -- 12. Diabetes does not accelerate cardiac hypertrophy in spontaneously hypertensive rats (SHR) -- 13. A close correlation of fasting insulin levels to blood pressure in obese children -- C. Pathophysiological Aspects of Cardiovascular Dysfunction in Diabetes -- 14. Cardiovascular involvements in a new spontaneously diabetic (WBN/Kob) rat -- 15. Biochemical and morphologic alterations in cardiac myocytes in streptozotocin-induced diabetic rats -- 16. Diabetes prolongs the action potential duration in rat ventricular muscle probably via enhanced calcium current -- 17. Increases in voltage-sensitive calcium channel of cardiac and skeletal muscle in streptozotocin-induced diabetic rats -- 18. Changes in cell morphology, [Ca2+]i and pHi during metabolic inhibition in isolated myocytes of diabetic rats using dual-loading of fura-2 and BCECF -- 19. Abnormal phosphorylation: Cause of reduced responsiveness to isoproterenol in diabetic heart -- 20. Electron microscopic cytochemical studies on ATPase and acid phosphatase activities of cardiac myocytes in streptozotocin induced diabetic rats -- 21. Myocardial isoenzyme distribution in chronic diabetes: Comparison with isoproterenol-induced chronic myocardial damage -- 22. In vivo 31-NMR spectroscopic investigation of myocardial energy metabolism in alloxan-induced diabetic rabbits -- 23. Characterization of beta-adrenoceptors in sinoatrial node and left ventricular myocardium of diabetic rat hearts by quantitative autoradiography -- 24. Effects of zinc deficiency on heart catecholamine concentrations in normal and diabetic rats -- 25. Atrial natriuretic peptide levels in plasma and atrial auricles of the non-obese diabetic (NOD) mouse -- D. Pharmacological and Therapeutic Aspects of Diabetic Heart -- 26. Effects of beta-adrenoceptor blocking agents on myocardium isolated from experimentally diabetic rats -- 27. Effects of autonomic agents on isolated and perfused hearts of streptozotocin-induced diabetic rats -- 28. Insulin-like actions of vanadyl sulfate trihydrate in streptozotocin- diabetic rats -- 29. Different cardiac effects of hypoglycaemic sulphonylurea compounds -- 30. Reversibility of diabetic cardiomyopathy by therapeutic interventions in mild diabetes -- 31. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyltransferase inhibitor etomoxir -- 32. Abnormal mitochondrial oxidative phosphorylation of ischaemic and reperfused myocardium reversed by L-propionyl-carnitine